Mite allergen Der-p2 triggers human B lymphocyte activation and Toll-like receptor-4 induction

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Tsai, Jaw Ji ^a,b   Liu, Shing Hwa ^b   Yin, Sui Chu ^c   Yang, Cheng Ning ^d   Hsu, Hong Sheng ^a   Chen, Wen Bao ^a   Liao, En Chih ^b   Lee, Wen Jane ^b   Pan, Hung Chuan ^a,b   Sheu, Meei Ling ^a,b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DEXAMETHASONE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITE ALLERGEN DER P2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NEUTRALIZING ANTIBODY; PROTEIN MD 2; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; DERP2 ALLERGEN, DERMATOPHAGOIDES PTERONYSSINUS; DUSP1 PROTEIN, HUMAN; LY96 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ALLERGIC DISEASE; ARTICLE; B LYMPHOCYTE ACTIVATION; CYTOKINE RESPONSE; DEPHOSPHORYLATION; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; B LYMPHOCYTE; BIOLOGICAL MODEL; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DERMATOPHAGOIDES PTERONYSSINUS; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MITE; MOUSE; PHOSPHORYLATION;

ACARI; PYROGLYPHIDAE;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CYTOKINES; DERMATOPHAGOIDES PTERONYSSINUS; DEXAMETHASONE; DUAL SPECIFICITY PHOSPHATASE 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE ANTIGEN 96; MICE; MITES; MODELS, IMMUNOLOGICAL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 80052511994     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023249     Document Type: Article

References (45)

1. Pucci S, Incorvaia C, (2008) Allergy as an organ and a systemic disease. Clin Exp Immunol 153 (Suppl 1): 1-2.
2. Rudeschko O, Machnik A, Dorfelt H, Kaatz HH, Schlott B, et al. (2004) A novel inhalation allergen present in the working environment of beekeepers. Allergy 59: 332-337.
3. Trombone AP, Tobias KR, Ferriani VP, Schuurman J, Aalberse RC, et al. (2002) Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy 32: 1323-1328.
4. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, et al. (2009) Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457: 585-588.
5. Abreu MT, Arditi M, (2004) Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr 144: 421-429.
6. Tsai JJ, Liu YH, Shen HD, Huang SH, Han SH, (2002) Prevention of Der p2-induced allergic airway inflammation by Mycobacterium-bacillus Calmette Guerin. J Microbiol Immunol Infect 35: 152-158.
7. Ghaemmaghami AM, Shakib F, (2002) Human T cells that have been conditioned by the proteolytic activity of the major dust mite allergen Der p 1 trigger enhanced immunoglobulin E synthesis by B cells. Clin Exp Allergy 32: 728-732.
8. Zouali M, (2008) B lymphocytes-chief players and therapeutic targets in autoimmune diseases. Front Biosci 13: 4852-4861.
9. Viau M, Zouali M, (2005) B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol 114: 17-26.
10. Abreu MT, Arditi M, (2004) Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr 144: 421-429.
11. Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, et al. (2004) Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun 72: 788-794.
12. Jeyaseelan S, Young SK, Yamamoto M, Arndt PG, Akira S, et al. (2006) Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa. J Immunol 177: 538-547.
13. Chaplin DD, (2010) Overview of the immune response. J Allergy Clin Immunol 125: S3-23.
14. Wang X, Moser C, Louboutin JP, Lysenko ES, Weiner DJ, et al. (2002) Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 168: 810-815.
15. Jeyaseelan S, Young SK, Yamamoto M, Arndt PG, Akira S, et al. (2006) Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa. J Immunol 177: 538-547.
16. Wang X, Moser C, Louboutin JP, Lysenko ES, Weiner DJ, et al. (2002) Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 168: 810-815.
17. Viriyakosol S, Matthias MA, Swancutt MA, Kirkland TN, Vinetz JM, (2006) Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun 74: 887-895.
18. Viau M, Zouali M, (2005) B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol 114: 17-26.
19. Okumura A, Pitha PM, Yoshimura A, Harty RN, (2010) Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. J Virol 84: 27-33.
20. Dong C, Davis RJ, Flavell RA, (2002) MAP kinases in the immune response. Annu Rev Immunol 20: 55-72.
21. Viau M, Zouali M, (2005) B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol 114: 17-26.
22. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, et al. (2006) MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 203: 131-140.
23. Clark AR, (2003) MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J Endocrinol 178: 5-12.
24. Owens DM, Keyse SM, (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26: 3203-3213.
25. Viau M, Zouali M, (2005) B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol 114: 17-26.
26. Abreu MT, Arditi M, (2004) Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr 144: 421-429.
27. Chaplin DD, (2010) Overview of the immune response. J Allergy Clin Immunol 125: S3-23.
28. Cohen-Sfady M, Nussbaum G, Pevsner-Fischer M, Mor F, Carmi P, et al. (2005) Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol 175: 3594-3602.
29. Xaus J, Comalada M, Valledor AF, Cardo M, Herrero C, et al. (2001) Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology 204: 543-550.
30. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ, (2007) Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109: 4313-4319.
31. Liu CF, Chen YL, Chang WT, Shieh CC, Yu CK, et al. (2005) Mite allergen induces nitric oxide production in alveolar macrophage cell lines via CD14/toll-like receptor 4, and is inhibited by surfactant protein D. Clin Exp Allergy 35: 1615-1624.
32. Poltorak A, He X, Smirnova I, Liu MY, Van HC, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
33. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752.
34. Zhao H, Leu SW, Shi L, Dedaj R, Zhao G, et al. (2010) TLR4 is a negative regulator in noninfectious lung inflammation. J Immunol 184: 5308-5314.
35. Gruber A, Mancek M, Wagner H, Kirschning CJ, Jerala R, (2004) Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J Biol Chem 279: 28475-28482.
36. Haagenson KK, Wu GS, (2010) Mitogen activated protein kinase phosphatases and cancer. Cancer Biol Ther 9: 337-340.
37. Li L, Chen SF, Liu Y, (2009) MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. Int J Clin Exp Med 2: 48-67.
38. Clark AR, (2003) MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J Endocrinol 178: 5-12.
39. Wang X, Liu Y, (2007) Regulation of innate immune response by MAP kinase phosphatase-1. Cell Signal 19: 1372-1382.
40. Owens DM, Keyse SM, (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26: 3203-3213.
41. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, et al. (2006) MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 203: 131-140.
42. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ, (2007) Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109: 4313-4319.
43. Wang X, Nelin LD, Kuhlman JR, Meng X, Welty SE, et al. (2008) The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia. Life Sci 83: 671-680.
44. King EM, Holden NS, Gong W, Rider CF, Newton R, (2009) Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. J Biol Chem 284: 26803-26815.
45. Liu SH, Yang CN, Pan HC, Sung YJ, Liao KK, et al. (2010) IL-13 downregulates PPAR-gamma/heme oxygenase-1 via ER stress-stimulated calpain activation: aggravation of activated microglia death. Cell Mol Life Sci 67: 1465-1476.